Keywords: progress, ambisome, usa, nexstar, liposomal, amphotericin, product

Progress With AmBisome In USA

Article | 17 July 1997

Print This

NeXstar's liposomal amphotericin B product AmBisome has beenrecommended for approval in the USA as a therapy for presumed fungal infections ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in